Navigation Links
UC San Diego computer scientists lauded for computer systems security, bioinformatics work
Date:12/8/2010

research groups in the Department of Computer Science and Engineering at UC San Diego. Savage is also the Acting Director of the UC San Diego Center for Networked Systems. His interests range from the economics of e-crime, to characterizing availability, to automotive systems to routing protocols and data center virtualization.

Bioinformatics Advances

UC San Diego computer science professor Pavel Pevzner's work has focused broadly on algorithmic aspects of bioinformatics. Bioinformatics has become a part of modern biology and often dictates new fashions, enables new approaches, and drives further biological developments. Pevzner's work focuses of DNA sequencing, proteomics, and genome rearrangements, the key areas of algorithmic biology. He authored influential graduate and undegraduate textbooks on bioinformatics algorithms and is now interested in new approaches to interdisciplinary computer science education and introducing computer science to education of biologists.

Pavel Pevzner is the Ronald R. Taylor Professor of Computer Science at UC San Diego; Director of the NIH Center for Computational Mass Spectrometry; and a Howard Hughes Medical Institute (HHMI) Professor.

ACM Fellows

The 2010 ACM Fellows have made advances in technology and contributions to the computing community that are meeting the dynamic demands of the 21st century, according to ACM President Alain Chesnais. "Their ability to think critically and solve problems creatively is enabling great advances on an international scale. The selection of this year's Fellows reflects broad international representation of the highest achievements in computing, which are advancing the quality of life throughout society," said Chesnais.

Fellow is the ACM's most prestigious member grade, recognizing the top 1 percent of ACM members for their outstanding accomplishments in computing and information technology, and/or outstanding service to ACM a
'/>"/>

Contact: Daniel Kane
dbkane@ucsd.edu
858-534-3262
University of California - San Diego
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. NIH doles out $3M in new innovator awards to 2 UC San Diego faculty
2. UC San Diego bioengineers fill holes in science of cellular self-organization
3. San Diego Supercomputer Center and UCSD announce Triton Resource
4. Field-hospital-on-a-chip project awarded to nanoengineer from UC San Diego
5. UC San Diego researchers use metagene portraits to reveal distinct stages of kidney formation
6. UC San Diego and Genentech scientists develop potentially disruptive antibody sequencing technology
7. UC San Diego senior named Churchill Scholar for extraordinary undergraduate research
8. UC San Diego bioengineering professor trey ideker wins 2009 Overton Prize
9. New method developed by UC San Diego bioengineers gives regenerative medicine a boost
10. Regional partnership to develop algal biofuels gets backing of San Diego leaders
11. UC San Diegos $3 million NSF grant to fund science festivals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/10/2015)... 10, 2015 Transforming How We ... "Personalized Medicine in Human Space Flight" by ... Goodwin , Ph.D. was recently featured by Springer Science ... years. Specifically, "Personalized Medicine in Human Space ... published in 2013 and 2014 from Springer in the ...
(Date:3/5/2015)... SAO PAULO , March 5, 2015 In ... with 41 percent of companies already using these solutions and ... of 2015. Of the latter, approximately 25 percent of the ... time. While the majority of companies in the ... is anticipated that the hybrid model will command significant attention ...
(Date:3/2/2015)... March 2, 2015 Synaptics Inc. (NASDAQ: ... human interface solutions, today announced a new implementation ... to enable rapid and secure transactions and reliable ... gaming is a turnkey solution providing mouse and ... quickly integrate fingerprint ID solutions into their product ...
Breaking Biology News(10 mins):"Personalized Medicine in Human Space Flight" Listed Among Most Influential Papers of 2013 and 2014 2Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 2Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 3Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 4Synaptics Unveils New Fingerprint ID Solution for Gamers 2Synaptics Unveils New Fingerprint ID Solution for Gamers 3
... risk of acquiring HIV rises during pregnancy, according to ... by researchers at the Johns Hopkins Bloomberg School of ... even after researchers controlled for behavior and other factors ... published in the September 30, 2005, edition of The ...
... trial, a new drug that selectively blocks immune ... kidney transplant rejection as cyclosporine, the standard anti-rejection ... drug, a co-stimulatory blocker called belatacept (LEA29Y), also ... the toxic side effects associated with standard anti-rejection ...
... have tracked down the biological trigger that gives ... bone disorder that can cause blindness and deafness. ... and could lead to new treatments for osteoporosis ... team from Lawrence Livermore and Lawrence Berkeley national ...
Cached Biology News:Pregnant women at higher risk for HIV, Uganda study finds 2New type of rejection blocker protects kidneys after transplant 2New type of rejection blocker protects kidneys after transplant 3New type of rejection blocker protects kidneys after transplant 4Researchers track down cause of a disfiguring bone disorder 2Researchers track down cause of a disfiguring bone disorder 3
(Date:3/29/2015)... , March 29, 2015  Caris ... study data in small cell cervical cancer ... Caris Molecular Intelligence®, the company,s panomic, comprehensive ... gene mutations which may explain sensitivities and ... that identification of certain biomarkers may guide ...
(Date:3/27/2015)... RI (PRWEB) March 27, 2015 Earlier ... for the promotion of hair regrowth in adult men ... classifications I-II or Norwood Hamilton classifications of IIa-V and ... an industry plagued by products that over-promise and under-deliver, ... Capillus272Pro™, renewing faith and confidence among more than 80 ...
(Date:3/27/2015)... -- Neogen Corporation (NASDAQ: NEOG ) announced today that ... in accordance with Securities and Exchange Commission rule 10b5-1. ... Corporation, is a minority owner of this entity that ... Herbert does not have control of this entity, but ... for a portion of the shares owned by that ...
(Date:3/27/2015)... , March 27, 2015 Working ... Free Hospital in London , Richmond Pharmacology ... a global Phase 3 study for an investigational RNAi therapeutic ... orphan disease affecting the nerves and heart. ... Detail Based at St Georges University of ...
Breaking Biology Technology:Study Using Caris Molecular Intelligence Multiplatform Tumor Profiling Identifies Potential Treatment Strategies for Small Cell Cervical Cancer 2Study Using Caris Molecular Intelligence Multiplatform Tumor Profiling Identifies Potential Treatment Strategies for Small Cell Cervical Cancer 3Dr. Robert Leonard Applauds FDA Clearance of Capillus272Pro™ Hair Loss Laser Cap 2Neogen CEO adopts 10b5-1 Trading Plan 2
... Leonhardt,s Launchpads ( www.leonhardtslaunchpads.com ), at the ... Center ( www.uncm.edu/STIC.php ), 2330 Circadian Way, Santa ... Grand Opening on Tuesday, November 9th from 3pm ... incubator for startup businesses and high-potential entrepreneurs in ...
... Inc. Prices $50 Million Public Offering ... ... lpUnit=,PRN,; --> ... ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. for (var ...
... Davis Phinney Foundation ( http://www.davisphinneyfoundation.org ), a non-profit foundation ... help people to live well with Parkinson,s disease, today ... Exercise and Parkinson,s: Questions and Answers from the Experts ... experts in the fields of physical therapy and exercise ...
Cached Biology Technology:OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 2OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 3OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 4OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 5OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 6OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 7OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 8OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 9Davis Phinney Foundation Launches Exercise-Focused Tools to Help People Live Well With Parkinson's Disease 2Davis Phinney Foundation Launches Exercise-Focused Tools to Help People Live Well With Parkinson's Disease 3Davis Phinney Foundation Launches Exercise-Focused Tools to Help People Live Well With Parkinson's Disease 4
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
TXNL2 Antibody...
Biology Products: